Holen Sie sich die Stockscreener-App
1.15
6.48%
0.07
Schlusskurs vom Vortag:
$1.08
Offen:
$1.07
24-Stunden-Volumen:
246.28K
Relative Volume:
0.54
Marktkapitalisierung:
$14.87M
Einnahmen:
$11.41M
Nettoeinkommen (Verlust:
$-38.92M
KGV:
-0.2355
EPS:
-4.8828
Netto-Cashflow:
$-30.46M
1W Leistung:
+11.65%
1M Leistung:
+28.29%
6M Leistung:
-33.14%
1J Leistung:
-63.38%
1-Tages-Spanne:
$1.07
$1.21
1-Wochen-Bereich:
$0.9501
$1.21
52-Wochen-Spanne:
$0.771
$3.4094
Curis Inc Stock (CRIS) Company Profile
Firmenname
Curis Inc
Sektor
Branche
Telefon
617-503-6500
Adresse
128 SPRING STREET, LEXINGTON, MA
Compare CRIS vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CRIS
Curis Inc
|
1.15 | 13.96M | 11.41M | -38.92M | -30.46M | -4.8828 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Curis Inc Stock (CRIS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-19 | Fortgesetzt | H.C. Wainwright | Buy |
| 2023-11-17 | Eingeleitet | Truist | Buy |
| 2022-04-04 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2021-10-13 | Eingeleitet | Raymond James | Outperform |
| 2021-03-25 | Eingeleitet | B. Riley Securities | Buy |
| 2020-07-29 | Eingeleitet | Laidlaw | Buy |
| 2020-07-17 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-10-24 | Eingeleitet | Guggenheim | Buy |
| 2016-03-02 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
| 2015-11-09 | Bestätigt | ROTH Capital | Buy |
| 2015-08-11 | Eingeleitet | FBR Capital | Outperform |
| 2015-01-22 | Bestätigt | Oppenheimer | Outperform |
| 2015-01-21 | Bestätigt | ROTH Capital | Buy |
| 2014-05-09 | Bestätigt | Oppenheimer | Outperform |
| 2013-10-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2013-09-30 | Eingeleitet | Chardan Capital Markets | Buy |
| 2012-11-14 | Eingeleitet | Stifel Nicolaus | Hold |
| 2012-01-31 | Bestätigt | Brean Murray | Buy |
| 2012-01-31 | Bestätigt | Summer Street Research | Buy |
| 2011-12-09 | Eingeleitet | Oppenheimer | Outperform |
| 2011-10-06 | Eingeleitet | Summer Street Research | Buy |
| 2011-09-22 | Eingeleitet | MLV Capital | Buy |
| 2011-03-21 | Bestätigt | Brean Murray | Buy |
| 2010-02-26 | Bestätigt | Roth Capital | Buy |
| 2010-01-07 | Eingeleitet | Roth Capital | Buy |
Alle ansehen
Curis Inc Aktie (CRIS) Neueste Nachrichten
Curis (CRIS) Moves to Offer Over 107 Million Shares of Common St - GuruFocus
Curis Provides Third Quarter 2024 Business Update - GuruFocus
According to the latest filing from the U.S. Securities and Exchange Commission (SEC), some shareholders of the biopharmaceutical company Curis Inc plan to resell their ordinary shares in the open market in an irregular and batch-by-batch manner. - Bitget
Support Test: Will Curis Inc benefit from AI trendsTrade Analysis Summary & Long-Term Growth Portfolio Plans - baoquankhu1.vn
What are Curis Inc.’s recent SEC filings showing2025 Key Lessons & Real-Time Buy Signal Notifications - mfd.ru
Is Curis Inc. (CUS0) stock positioned for secular growthLayoff News & Low Drawdown Trading Strategies - mfd.ru
How The Narrative Around Curis (CRIS) Is Shifting As Assumptions Change Not The US$14 Target - Yahoo Finance
Curis regains compliance with Nasdaq listing standards, enters monitoring period - Investing.com
Curis Regains Nasdaq Compliance, Remains Under Monitoring Period - TipRanks
Curis (CRIS) targets major share hike to unlock PIPE and new 2026 equity plan - Stock Titan
Curis Advances Clinical Pipeline with Focus on Leukemia Treatments - AD HOC NEWS
Buyout Rumor: Is Curis Inc a potential multi bagger2025 Market WrapUp & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Rate Cut: How does 60 Degrees Pharmaceuticals Inc score in quality rankings2025 Market WrapUp & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Curis (CRIS) to Release Earnings on Wednesday - Defense World
Panic Selling: Is Curis Inc exposed to political riskQuarterly Portfolio Summary & High Accuracy Swing Trade Signals - baoquankhu1.vn
Aug Drivers: Is Curis Inc stock a value trap2025 Technical Patterns & Smart Allocation Stock Tips - baoquankhu1.vn
Is Curis Inc. stock a value trapJuly 2025 Chart Watch & High Accuracy Swing Trade Signals - mfd.ru
Curis Targets BTKi-Exposed CLL With New Emavusertib Combo Trial: What Investors Should Watch - TipRanks
Bond Watch: Is Curis Inc exposed to political risk2025 Macro Impact & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Curis shares jump after lining up up to $80.8m in private placement financing - MSN
Curis Announces Closing of Private Placement Totaling up to $80.8 Million in Gross Proceeds - marketscreener.com
Looking At The Narrative For Curis CRIS After Fresh Funding And Fair Value Reset - Yahoo Finance
Curis closes private placement for up to $80.8 million in funding - Investing.com Nigeria
Curis announces closing of private placement totaling up to $80.8 million in gross proceeds - marketscreener.com
Stock Market Recap: Can Curis Inc. stock beat analyst upgradesQuarterly Profit Review & Daily Chart Pattern Signals - Улправда
Is Curis Inc. (CUS0) stock a top dividend aristocrat candidateJuly 2025 Update & Free Risk Controlled Daily Trade Plans - Улправда
Curis prices private placement of $80.8M - MSN
Volume Recap: Can Curis Inc. stock maintain growth trajectoryEntry Point & Consistent Income Trade Recommendations - ulpravda.ru
Curis (NASDAQ: CRIS) sets PIPE financing with warrants and targets 2027 cash runway - Stock Titan
Curis Announces PIPE Financing and Strategic Capital Strengthening - TipRanks
Curis Signs Multiple Material Agreements - TradingView — Track All Markets
Curis announces $80.8 million private placement to fund drug development By Investing.com - Investing.com Nigeria
Curis Inc: Can This Beaten-Down Cancer Stock Still Surprise The Market? - AD HOC NEWS
Aug Breakouts: Can Curis Inc stock maintain growth trajectoryDividend Hike & Daily Profit Maximizing Trade Tips - moha.gov.vn
Curis, Inc. announced that it expects to receive $20.195 million in funding - marketscreener.com
Curis announces $80.8M private placement - TipRanks
Crude Oil Down 2%; ISM Services PMI Surges In December - Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Curis (CRIS) Secures PIPE Deal for Up to $80.8M - GuruFocus
Curis announces pricing of private placement totaling up to $80.8 million in gross proceeds - marketscreener.com
Curis stock soars after securing $80.8 million private placement deal By Investing.com - Investing.com South Africa
Curis stock soars after securing $80.8 million private placement deal - Investing.com India
Curis Announces Pricing of Private Placement Totaling up to $80.8 Million in Gross Proceeds - PR Newswire
Can Curis Inc stock maintain growth trajectoryWeekly Investment Recap & Reliable Breakout Stock Forecasts - moha.gov.vn
Why Investors Shouldn't Be Surprised By Curis, Inc.'s (NASDAQ:CRIS) 27% Share Price Plunge - simplywall.st
ETF Watch: Will PWV stock outperform global peersJuly 2025 Retail & Risk Adjusted Buy and Sell Alerts - moha.gov.vn
CUS0 Stock Price and Chart — TRADEGATE:CUS0 - TradingView — Track All Markets
Can Curis Inc. stock attract ESG capital inflowsWeekly Market Outlook & Long Hold Capital Preservation Plans - Улправда
Finanzdaten der Curis Inc-Aktie (CRIS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):